The Genus Eranthis: Prospects of Research on Its Phytochemistry, Pharmacology, and Biotechnology
Plants · 07.11.2023 · 12 (22) · 3795
DOI: 10.3390/plants12223795 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Plants, online erschienen am 07.11.2023. Verfasst von Andrey S Erst und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central Siberian Botanical Garden, Siberian Branch of Russian Academy of Sciences (CSBG SB RAS), Novosibirsk 630090, Russia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The work was supported by the Russian Science Foundation, grant No. 23-14-00230, https://rscf.ru/project/23-14-00230/, Russian Science Foundation.
Abstract (Originalsprache)
This review summarizes information about the chemical composition and beneficial properties of species of the genus Eranthis Salisb. from the world’s flora. To date, seven out of ~14 species found in Asia and parts of Europe have been studied to various degrees. Here, data are presented on the diversity of sets of chromones, furochromones, triterpene saponins, coumarins, and other classes of secondary metabolites of Eranthis species according to the literature. For new compounds—isolated from Eranthis for the first time—structural formulas are also provided. Among the new compounds, chromones and coumarins predominate, as do triterpene saponins of the olean and cycloartane series and lectin. The results of pharmacological studies are presented showing anti-inflammatory, antioxidant, antiviral, and other types of biological activities found in extracts, in their fractions, and in individual compounds of the aboveground and underground organs and parts of Eranthis species. Despite the limited geographic range of Eranthis plants, it is possible to search for active substances, develop methods for biological and chemical synthesis of the isolated substances, and create a finished therapeutic substance based on them. In addition, it is feasible to obtain the desired standardized pure materials from Eranthis species grown in vitro.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Siberian Botanical Garden, Siberian Branch of Russian Academy of Sciences (CSBG SB RAS), Novosibirsk 630090, Russia.
- Komarov Botanical Institute, Russian Academy of Sciences (BIN RAS), St. Petersburg 197022, Russia.
- Central Research Laboratory, Siberian State Medical University, Tomsk 634050, Russia.
- State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences, Beijing 100093, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Andrey S Erst, Natalia V Petrova, Olga A Kaidash, Wei Wang, Vera A Kostikova
Förderung
- The work was supported by the Russian Science Foundation, grant No. 23-14-00230, https://rscf.ru/project/23-14-00230/
- Russian Science Foundation
Zitieren
APA
Erst, A. S., Petrova, N. V., Kaidash, O. A., Wang, W., & Kostikova, V. A. (2023). The Genus Eranthis: Prospects of Research on Its Phytochemistry, Pharmacology, and Biotechnology. Plants, 12(22), 3795. https://doi.org/10.3390/plants12223795
Vancouver
Erst AS, Petrova NV, Kaidash OA, Wang W, Kostikova VA. The Genus Eranthis: Prospects of Research on Its Phytochemistry, Pharmacology, and Biotechnology. Plants. 2023;12(22):3795. doi:10.3390/plants12223795
BibTeX
@article{Erst2023,
author = {Erst, Andrey S and Petrova, Natalia V and Kaidash, Olga A and Wang, Wei and Kostikova, Vera A},
title = {The Genus Eranthis: Prospects of Research on Its Phytochemistry, Pharmacology, and Biotechnology},
journal = {Plants},
year = {2023},
volume = {12},
number = {22},
pages = {3795},
doi = {10.3390/plants12223795}
}
EUVIMED